Member Info for BOJO2020

£1k for each penny rise! Good luck.

X

Good call (I believe) on IQAI. Tiny MC could do 100% easy. Or nowt!

ATB

I’ll go with

POLX 64p
Sclp. 19.75p
Redx. 81p

Many Thanks

I have to say I think you are all being level headed about this. It would be oh so easy to go all ultra ramp or deramp about the current situation. This thread is very credible IMO and I find myself in broad agreement.

Disclosure; I bought in after CRL, sold a few and now riding free. I intend to see where this goes.

So we have one person relaying to a third party that they have spoken to another third party about a pivotal FDA decision that is still not guaranteed.

Wakey wakey Mr Waite! Very tenuous indeed…

So top up opportunity as news is in the near, medium, and longer term pipeline.

Or hold patiently.

So why not post it here for others to share.

https://www.lse.co.uk/rns/SCLP/results-for-the-year-ended-30-april-2021-i6ssw90wur5gkf5.html

And yes these are early stage but it’s all lined up for next 15 months

Whenever I buy the dips with Sclp it has never let me down. I remember licking my lips as I just started investing with Scancell maybe 18months ago when the share price dropped to a delectable 5.4p. What I would give to go back in time and buy more back then!

Anyway, my buy @ £1900.94 so another 9881 share to add to my small pile.

ATB

Maf,

Just to add to that. One can see how good support is following a fund raise. ECR collapsed where as Angle and Sclp thrive in such circumstances.

Personally I think SAR would have excellent support as they have a strong investment case. Just my opinion.

ATB

Different brokers open different doors/contacts/opportunities.

I know with ECR minerals new brokers means another placing lol.

Tech,

As you are no doubt still in your research phase (although I note you have bought in!) I thought you may enjoy this. It is just one of many discussions regarding the relevance of liquid biopsy.

Professor Stebbin looks and sounds geeky but he has achieved a great deal in his relatively short career.

Apologies if you have watched already but I personally do not tire of watching these people discuss breaking new scientific boundaries and research. Courtesy of Parsortix of course!

https://youtu.be/EsiKCTA3wWM

We are still waiting on Newcrest to announce an intention to drill and this is holding back the SP IMO.

JS,

Looks like a pretty wide spread! But each to their own strategy…

** excuse typo both $

Have you Valneva fans looked at Inovio. Discounted from $20 dollars to €6.70. Also a promising COVID vax which has been unlucky. Could be very promising but previous highs luck unlikely.

ATB

Added more this morning now I will leave them in the bottom drawer for a few years

Waking up. Announcement imminent IMO. Glad I topped up today at 17.5p. I think! Let’s see

Just watching a webinar between Amati Global Investments and POLAREAN. This would be prior to their FDA application. PolX say (Richard Hullihen) that when dealing with FDA, they would normally expect face to face meeting. However due to COVID, they were allowed only to listen in to meetings and contribute verbally with FDA. Whilst FDA members taking part in the same meeting were able to carry out a normal visual and audio Zoom meeting between themselves.

Sounds bloody odd to me. Wonder if we have had the same with our application…

I have been watching this one for two years. Hopefully I have timed my buy well. The next two to three years could be very interesting.

ATB

https://www.proactiveinvestors.co.uk/companies/news/964012/redx-pharma-plc-lonredx-presenting-at-the-proactive-one2one-virtual-forum---october-2021-964012.html

Five candidates looking at phase 1 & 2 over next 15 months ish.

£40 million in bank
Milestones agreements in place
Involvement with AZ, Sanofi and Jazz Pharmaceuticals.
Rock 2 inhibitor is well tolerated thus far which is rare and sets it apart…

Majority share holder is Redmile Investments who were forced to take over a couple of years back. They will look to sell down but that’s actually a good thing IMO.

Could be revisiting £1.20 again with further phase 1 data released? If it drops below 75p, I will add more.

Not many of these baby bios left on the shelf!